Proceeds will fund the registrational STOP-Cdiff (SIDIPREV™ Trial On Prevention of C. difficile Infections) trial for SIDIPREV™, positioned to become the first prevention against C. difficile, a ...
GenePOC, has received CE marking for its second bacteriological test, GenePOC CDiff, and for its centripetal sample to result instrument, revogene GenePOC, Inc. (GenePOC), a member of Debiopharm Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results